For COVID-19 Vaccines, ACIP Will Be a Critical Gatekeeper
Eric Topol and vaccine expert Paul Offit have a one-on-one to discuss where we are regarding the development, authorization, and/or licensure of vaccines to prevent COVID-19.
Eric Topol and vaccine expert Paul Offit have a one-on-one to discuss where we are regarding the development, authorization, and/or licensure of vaccines to prevent COVID-19.
Nature Medicine – The study on APOE4 homozygosity indicates a genetic variant of Alzheimer’s disease with early symptom onset and distinct biomarker progression, highlighting the…
Long Covid provides an opportunity to understand how acute infections cause chronic disease
Nature Medicine – The study on APOE4 homozygosity indicates a genetic variant of Alzheimer’s disease with early symptom onset and distinct biomarker progression, highlighting the…
Nature Medicine – The study on APOE4 homozygosity indicates a genetic variant of Alzheimer’s disease with early symptom onset and distinct biomarker progression, highlighting the…
Nature Nanotechnology – The ability to vaccinate against multiple related pathogens is a significant advantage. Here, the authors report on quartets of linked receptor-binding domains…
CEP290-associated inherited retinal degeneration causes severe early-onset vision loss due to pathogenic variants in CEP290. EDIT-101 is a clustered regularly interspaced short palindromic repeats …
This study showed extended benefits of nirmatrelvir–ritonavir for reducing the risk of post-acute inpatient death as well as cardiovascular and respiratory complications among patients admitted…
Eric Topol is a Professor and EVP at Scripps Research, and the Founding Director of the Scripps Research Translational Institute. He has published over 1,300…
Editorial from The New England Journal of Medicine — Cell-free DNA for Colorectal Cancer Screening
This cohort study assesses the prevalence, underlying causes, and harms of diagnostic errors among hospitalized adults who died or were transferred to intensive care.